HealthLeaders-InterStudy, a leading provider of managed care industry intelligence, finds that five of Georgia's HMOs experienced enrollment declines in 2004. According to the latest issue of Georgia & Alabama Health Plan Analysis from HealthLeaders- InterStudy, the overall commercial HMO market share dropped by 2.2 percent.

"It's important to note that the members leaving HMOs are not joining the ranks of the uninsured," said Jan Shuxteau, HealthLeaders-InterStudy analyst. "They are moving to PPOs, and other coverage variations that suit their desires and pocketbooks."

Previous market share drops from year to year have been one to two percent.

  Other health plan news in Georgia and Alabama:    * APS Healthcare and UnitedHealthcare both won contracts for disease     management programs that target the aged, blind, and disabled portion     of the Medicaid population.   * UnitedHealthcare was awarded a single contract from the Georgia     Department of Community Health to administer the state employee health     plan.   * Seniors in Georgia can choose from 18 stand-alone Medicare prescription     drug plans, while those in Alabama have 17 choices.    About Health Plan Analysis 

Health Plan Analysis identifies key health plan trends, allowing healthcare businesses to create comprehensive strategic plans and sales strategies at state and local levels.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a company of Decision Resources, Inc. (http://www.decisionresources.com/), is the authoritative source for managed care data and analysis. For more information, please visit http://www.healthleaders-interstudy.com/.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Alex Jablokow   Decision Resources   781-296-2562   ajablokow@dresources.com 

SOURCE: HealthLeaders-InterStudy

CONTACT: Alex Jablokow of Decision Resources, +1-781-296-2562,
ajablokow@dresources.com

Despite Limited Diagnosed Prevalent Population, Crohn's Disease Drug Market Will Experience Steady Growth

View Now